Found 10 results

2010
ADVANCE Collaborative Group, Writing Committee, Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S et al..  2010.  The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax. Diabetologia. Epub. [IF 6.418]
2009
Heerspink HJL, Ninomiya T, Zoungas S, de Zeeuw D, Grobbee DE, Jardine M, Gallagher M, Roberts MA, Cass A, Neal B et al..  2009.  Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials . Lancet. 373:1009-1015.[IF28.638].
ADVANCE Collaborative Group, de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M et al..  2009.  Cognitive function and risks of cardiovascular disease and hypoglycaemia in people with type 2 diabetes; the ADVANCE trial. Diabetelogia. 52:2329-36.[IF6.418].
AdRem Project Team and ADVANCE Management Committee, [Writing Committee], Beulens JWJ, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA et al..  2009.  Effects of blood pressure lowering and intensive glucose control on incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia. 52:2027-36.[IF5.822].
ADVANCE Collaborative Group, de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S et al..  2009.  Routine blood pressure lowering and kidney disease in type 2 diabetes. J Am Soc Nephrol. 20:883-92.[IF7.111].
2008
ADVANCE Collaborative Group Writing Group, (Writing Committee), Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M et al..  2008.  Intensive blood glucose control on vascular outcomes in patients with type 2 diabetes . N Engl J Med . 358:2560-72.[IF52.589][Grant:ADVANCE&ProgramGrant].
Stolk RP, van Schooneveld MJ, Cruickshank JK, Hughes AD, Stanton A, Lu J, Patel A, Thom SA, Grobbee DE, Vingerling JR et al..  2008.  Retinal vascular lesions in patients with type 2 diabetes mellitus of Caucasian and Asian origin . baseline results from the AdRem study . Diabetes Care. 31 :708-13.[IF7.851].
AdRem Project Team and Adv Management, Writing Committee, Beulens JW, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, Patel A, Thom SAM et al..  2008.  Effects of blood pressure lowering on incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial . Proceedings of the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) . <i>Diabetologia</i>. 2008;51(Suppl 1):S476-S476. [IF 5.822]
2007
Patel A, ADVANCE Collaborative Group, (Writing Committee), MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N et al..  2007.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet . 370:829-40.[IF28.638].
Stolk RP, Vingerling JR, Kennedy Cruickshank J, Hughes AD, Stanton A, Juming L, Patel A, Thom SA, Grobbee DE, AdRem Project Team and ADVANCE Management Committee et al..  2007.  Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus. Contemp Clin Trials. 28:6-17.[ImpactFactor1.438].

Latest news

Recently added pages

Our focus

George Institute sites